The partners at the centre of Blis patent dispute named

The partners at the centre of Blis patent dispute named
The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015. (Image: NZME)
Denise McNabb
Two executives from Blis Technologies’ long-time European partner, Bluestone Pharma, are named on a patent application as inventors of two fermentation processes Blis claims as its own technology.The executives are Michael Faber, Swiss-registered Bluestone Pharma’s managing partner, and Karsten Brandt, its chief scientific officer. The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015 to distribute its healthcare products in Europe. At the time, Blis said the relationship with Bluestone Pharma (BP) hel...

More Markets

NZ shares finish flat as Sanford rises
Markets Market close

NZ shares finish flat as Sanford rises

Trading was heavy for a Friday with 38.56 million shares worth $193.38m changing hands.

Graham Skellern 15 Nov 2024
2 Cheap Cars profit down nearly 50%
Markets

2 Cheap Cars profit down nearly 50%

The CEO says he's never seen a market this volatile since founding the firm.

John Anthony 15 Nov 2024
Slump in NZ dollar shows no sign of abating
Markets

Slump in NZ dollar shows no sign of abating

The next near-term support level is at 57.75 US cents. 

Rebecca Howard 15 Nov 2024
Steel & Tube blames weak economy for four-month loss
Markets

Steel & Tube blames weak economy for four-month loss

Steel & Tube says it went into an operating loss of $5 million in the first four months of its financial year, with revenue falling sharply over the period due to low demand for steel.In a trading update, Steel & Tube said the first four months showed the weakness in the New Zeal...

Staff reporters 15 Nov 2024